Results 211 to 216 of about 44,873 (216)

SGLT2 inhibitor in a type 2 diabetes mellitus patient coexisted with central diabetes insipidus following hyperosmolar hyperglycemic state. [PDF]

BMC Endocr Disord
Liu S, Chen W, Zhao Y, Ma S, Shi B, Guo H.   +5 more
europepmc   +1 more source

Impact of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors on Nocturnal Polyuria: A Cross-Sectional Study. [PDF]

Cureus
Sato S, Yoshimura T, Komori K, Saheki T, Kobayashi T, Fukunaga K, Imachi H, Murao K.   +7 more
europepmc   +1 more source

Clinical and genetic analysis of X-linked nephrogenic diabetes insipidus caused by a novel <i>AVPR2</i> mutation (NM_000054.6:exon3:c.245G>A (p.Cys82Tyr)) in a Chinese boy. [PDF]

Intractable Rare Dis Res
Yang J, Sun Y, Chen C.
europepmc   +1 more source

Case Report: New insights about clinical manifestations of patients with <i>GCK</i> genetic variants. [PDF]

Front Endocrinol (Lausanne)
de Souza RB, Abreu GM, Bernardo MC, Tarantino RM, Rodacki M, Zajdenverg L, de Andrade AF, Nicolay DS, da Fonseca ACP, Salum KCR, Szundy Berardo R, Luescher JL, Zembrzuski VM, Cabello PH, Campos Junior M.   +14 more
europepmc   +1 more source